Journal
CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 15, Issue 6, Pages 417-424Publisher
SPRINGER INT PUBL AG
DOI: 10.1007/s12094-012-0982-0
Keywords
Basal cell carcinomas (BCC); Squamous cell carcinomas (SCC); Lipid nanoemulsions (NEs) and nanoparticles (NPs); Nanocarriers; Non-melanoma skin cancer
Categories
Funding
- CAPES (Coordenacao Aperfeicoamento de Pessoal de Nivel Superior)
- FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
Ask authors/readers for more resources
Basal cell carcinomas and squamous cell carcinomas are non-melanoma skin cancers reported to be among the most common malignancies, being responsible for high human morbidity. Conventional chemotherapy applied to these conditions shows non-specific targeting, thus severe adverse side effects are also commonly reported. New therapeutic strategies based on nanoparticulates technology have emerged as alternatives for site specific chemotherapy. Among the different types of nanoparticulates, lipid nanoemulsions and nanoparticles have several advantages for topical delivery of poorly soluble chemotherapeutics. These particles show sustained drug release and protection of loaded drugs from chemical degradation. This technology is promising to enhance the intracellular concentration of drugs and consequently reduce the cytotoxicity of skin chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available